Baclofen in the treatment of alcohol addiction : a French saga
In 2018, France granted an approval to baclofen for the treatment of alcohol-dependency. It is the culmination of a long saga that began in 2005 with the publication of the personal case of Dr Ameisen, followed in 2008 by a public book which achieved great success and an important echo in the French population and in the media. The weakness of scientific data contradicting peremptory positions on its effectiveness has generated strong tensions between supporters of scientific medicine and activists supporting baclofen. Indeed, the data from published clinical trials do not confirm a high level of efficacy. Nevertheless, baclofen has allowed new patients to consult in the hope of an improvement. This long story confirms the need to evaluate therapeutics according to scientifically validated experimental protocols in order to avoid the risks of deviance.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Revue medicale suisse - 17(2021), 742 vom: 09. Juni, Seite 1122-1125 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Le baclofène dans le traitement de la dépendance à l’alcool : une saga française |
|---|
| Beteiligte Personen: |
Paille, François [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 11.06.2021 Date Revised 11.06.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM326545964 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326545964 | ||
| 003 | DE-627 | ||
| 005 | 20231225194829.0 | ||
| 007 | tu | ||
| 008 | 231225s2021 xx ||||| 00| ||fre c | ||
| 028 | 5 | 2 | |a pubmed24n1088.xml |
| 035 | |a (DE-627)NLM326545964 | ||
| 035 | |a (NLM)34106538 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Paille, François |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Baclofen in the treatment of alcohol addiction |b a French saga |
| 246 | 3 | 3 | |a Le baclofène dans le traitement de la dépendance à l’alcool : une saga française |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 11.06.2021 | ||
| 500 | |a Date Revised 11.06.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In 2018, France granted an approval to baclofen for the treatment of alcohol-dependency. It is the culmination of a long saga that began in 2005 with the publication of the personal case of Dr Ameisen, followed in 2008 by a public book which achieved great success and an important echo in the French population and in the media. The weakness of scientific data contradicting peremptory positions on its effectiveness has generated strong tensions between supporters of scientific medicine and activists supporting baclofen. Indeed, the data from published clinical trials do not confirm a high level of efficacy. Nevertheless, baclofen has allowed new patients to consult in the hope of an improvement. This long story confirms the need to evaluate therapeutics according to scientifically validated experimental protocols in order to avoid the risks of deviance | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Baclofen |2 NLM | |
| 650 | 7 | |a H789N3FKE8 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Revue medicale suisse |d 2005 |g 17(2021), 742 vom: 09. Juni, Seite 1122-1125 |w (DE-627)NLM154244252 |x 1660-9379 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2021 |g number:742 |g day:09 |g month:06 |g pages:1122-1125 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2021 |e 742 |b 09 |c 06 |h 1122-1125 | ||